NYSE:DGX (USA) Also Trade In: Brazil Germany Mexico UK

Quest Diagnostics Inc $ 124.97 0.51 (0.41%)

Volume:
905,027
Avg Vol (1m):
1,221,113
Market Cap $:
16.84 Bil
Enterprise Value $:
20.43 Bil
P/E (TTM):
15.44
P/B:
2.64
Warning! GuruFocus has detected 1 Severe warning sign with DGX. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for Quest Diagnostics Inc () from 1996 to Jan 26 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Quest Diagnostics stock (DGX) PE ratio as of Jan 26 2021 is 15.44. More Details

Quest Diagnostics PE Ratio (TTM) Chart

EMBED

Quest Diagnostics PE Ratio (TTM) Historical Data

Total 1259
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Quest Diagnostics PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2021-01-2615.5 2020-11-2415.6
2021-01-2515.5 2020-11-2315.5
2021-01-2215.4 2020-11-2015.4
2021-01-2115.5 2020-11-1915.2
2021-01-2015.7 2020-11-1815.1
2021-01-1915.6 2020-11-1715.3
2021-01-1815.4 2020-11-1615.2
2021-01-1515.4 2020-11-1315.0
2021-01-1415.5 2020-11-1215.0
2021-01-1315.5 2020-11-1115.2
2021-01-1215.6 2020-11-1014.9
2021-01-1115.3 2020-11-0914.9
2021-01-0815.2 2020-11-0615.7
2021-01-0715.3 2020-11-0515.8
2021-01-0615.5 2020-11-0415.6
2021-01-0515.1 2020-11-0315.6
2021-01-0415.0 2020-11-0215.4
2021-01-0114.7 2020-10-3015.1
2020-12-3114.7 2020-10-2915.2
2020-12-3014.6 2020-10-2815.5
2020-12-2914.6 2020-10-2715.7
2020-12-2814.7 2020-10-2615.4
2020-12-2514.9 2020-10-2315.7
2020-12-2414.9 2020-10-2215.6
2020-12-2314.9 2020-10-2115.2
2020-12-2215.0 2020-10-2015.2
2020-12-2114.9 2020-10-1914.9
2020-12-1814.9 2020-10-1614.9
2020-12-1714.9 2020-10-1514.6
2020-12-1615.0 2020-10-1414.5
2020-12-1515.4 2020-10-1314.5
2020-12-1415.2 2020-10-1214.4
2020-12-1115.1 2020-10-0914.4
2020-12-1015.5 2020-10-0814.4
2020-12-0915.4 2020-10-0714.4
2020-12-0815.3 2020-10-0614.4
2020-12-0715.2 2020-10-0514.3
2020-12-0415.2 2020-10-0214.1
2020-12-0315.2 2020-10-0113.9
2020-12-0215.4 2020-09-3014.2
2020-12-0115.5 2020-09-2914.1
2020-11-3015.3 2020-09-2814.1
2020-11-2715.4 2020-09-2520.3
2020-11-2615.4 2020-09-2419.8
2020-11-2515.4 2020-09-2320.2

Quest Diagnostics PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Industry Healthcare » Medical Diagnostics & Research » NAICS : 621511 NAICS : 8071
Address 500 Plaza Drive, Secaucus, NJ, USA, 07094
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of 2,000 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.